TY - JOUR
T1 - Hazara virus infection is lethal for adult type I interferon receptor-knockout mice and may act as a surrogate for infection with the human-pathogenic Crimean-Congo hemorrhagic fever virus
AU - Dowall, Stuart
AU - Findlay-Wilson, Stephen
AU - Rayner, Emma
AU - Pearson, Geoff
AU - Pickersgill, Janice
AU - Rule, Antony
AU - Merredew, Natasha
AU - Smith, Hazel
AU - Chamberlain, John
AU - Hewson, Roger
PY - 2012/3
Y1 - 2012/3
N2 - Hazara virus (HAZV) is closely related to the Crimean-Congo hemorrhagic fever virus (CCHFV). HAZV has not been reported to cause human disease; work with infectious material can be carried out at containment level (CL)-2. By contrast, CCHFV causes a haemorrhagic fever in humans and requires CL-4 facilities. A disease model of HAZV infection in mice deficient in the type I interferon receptor is reported in this study. Dose-response effects were seen with higher doses, resulting in a shorter time to death and earlier detection of viral loads in organs. The lowest dose of 10 p.f.u. was still lethal in over 50% of the mice. Histopathological findings were identified in the liver, spleen and lymph nodes, with changes similar to a recent mouse model of CCHFV infection. The findings demonstrate that inoculation of mice with HAZV may act as a useful surrogate model for the testing of antiviral agents against CCHFV.
AB - Hazara virus (HAZV) is closely related to the Crimean-Congo hemorrhagic fever virus (CCHFV). HAZV has not been reported to cause human disease; work with infectious material can be carried out at containment level (CL)-2. By contrast, CCHFV causes a haemorrhagic fever in humans and requires CL-4 facilities. A disease model of HAZV infection in mice deficient in the type I interferon receptor is reported in this study. Dose-response effects were seen with higher doses, resulting in a shorter time to death and earlier detection of viral loads in organs. The lowest dose of 10 p.f.u. was still lethal in over 50% of the mice. Histopathological findings were identified in the liver, spleen and lymph nodes, with changes similar to a recent mouse model of CCHFV infection. The findings demonstrate that inoculation of mice with HAZV may act as a useful surrogate model for the testing of antiviral agents against CCHFV.
UR - http://www.scopus.com/inward/record.url?scp=84857072591&partnerID=8YFLogxK
U2 - 10.1099/vir.0.038455-0
DO - 10.1099/vir.0.038455-0
M3 - Article
C2 - 22090213
AN - SCOPUS:84857072591
VL - 93
SP - 560
EP - 564
JO - Journal of General Virology
JF - Journal of General Virology
SN - 0022-1317
IS - 3
ER -